Le Lézard
Classified in: Health
Subject: SVY

New Best Practices, LLC Study Tackles Challenge of Integrating Quality across Global Pharmaceutical or Medical Device Operations


CHAPEL HILL, N.C., Nov. 17, 2017 /PRNewswire/ -- Effectively integrating a quality organization across a global pharmaceutical or medical device company is a major challenge for the same reason it can produce amazing results: the world is a big place with many differences. On a more local front, companies seek to understand how a quality organization can move beyond simply ensuring product safety and compliance.

To address both these needs, Best Practices, LLC has published "Benchmarking Quality in the Biopharmaceutical & Medical Device Sectors," a wide-ranging research study that probes how both global and local quality teams can become more efficient, effective and add value for shareholders, patients, physicians and other stakeholders.

Some of the issues addressed in this new report include:

The full 121-page report contains more than 600 metrics, providing quality leaders with critical benchmarks that will allow them to compare their operations with those of leading organizations.

Best Practices, LLC engaged 23 quality leaders from 23 pharma and medical device companies through a benchmarking survey. Qualitative data was collected via deep-dive interviews with Quality leadership teams. This report includes segmented data for pharma and medical device companies.

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1473.htm.

For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.

SOURCE Best Practices, LLC


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: